p. 132−144
2090-7125
Vol.47/No.1
p. 145−157
2090-7125
Vol.47/No.1
p. 158−165
2090-7125
Vol.47/No.1
p. 166−175
2090-7125
Vol.47/No.1
p. 190−216
2090-7125
Vol.47/No.1
14 weeks. GnRH agonists such as goserelin can reduce uterine bulk by up to 60% and was initially used to convert a midline to Pfannenstiel incision in abdominal hysterectomy. The conversion of an abdominal to a potential vaginal hysterectomy by uterine size reduction would prove advantageous.
Objective: To evaluate the efficacy of the preoperative administration of GnRH agonist for women with enlarged uteri without prolapse in order to facilitate vaginal hysterectomy; in comparison with patients with enlarged uteri who underwent to direct Total abdominal hysterectomy for a similar indication (i.e. Menorrhagia).
Design: Prospective multicentre randomized controlled trial
Setting: Tertiary Center Hospitals
Methods: Women scheduled for hysterectomy for menorrhagia with non-prolapsing clinical uterine size of >14 weeks were offered an attempt for vaginal hysterectomy after pre-treatment with Goserelin for 3 months (Study group= 30). A group of women with comparable uterine size who underwent abdominal hysterectomy for similar indication served as (Control group=30). Pre- and postoperative data such as hemoglobin, myoma size, uterine weight, duration of procedure and complications, pain score, and length of hospital stay were collected prospectively.
Results: Both groups had comparable preoperative hemoglobin, body mass index and subjective preoperative uterine bulk (16.7±2.4 vs16.9±2.2 weeks). The uterine weight was lower in the study group (507.6±211 g) compared to the control group (728.8±189 g), P<0.001.The subjective mean decrease in clinical uterine bulk was 20%. The duration of surgery was nearly twice as long in vaginal (123.3±34.9 min) compared to abdominal hysterectomy (73.9±23.9 min), P< 0.001, but analgesia use and the length of inpatient stay were lower in the study group (2.4±1 days) compared to control group (4.97±1.5 days), P<0.001. No significant difference between the two groups as regards the rate of occurrence of surgical complications.
Conclusions: In women with >14 week size uteri, treatment with gonadotrophin agonists reduces uterine size sufficiently to allow safe vaginal hysterectomy. Although duration of surgery was longer, women who underwent vaginal hysterectomy required less analgesia and had shorter inpatient stay.
]]>
p. 217−225
2090-7125
Vol.47/No.1
p. 226−237
2090-7125
Vol.47/No.1
p. 238−248
2090-7125
Vol.47/No.1
p. 249−259
2090-7125
Vol.47/No.1
p. 260−278
2090-7125
Vol.47/No.1
p. 279−290
2090-7125
Vol.47/No.1
0.01) and the activity of ALAT and ALP was significant increases (P >0.05) in male and female rabbits at high doses only.
Conclusions: Some toxicological effects were observed after administration of aqueous leaves extract of Calotropis Procera at high doses in the long term for male and females rabbits
]]>
p. 291−300
2090-7125
Vol.47/No.1
p. 301−320
2090-7125
Vol.47/No.1
p. 321−333
2090-7125
Vol.47/No.1